CellDrop Biosciences

Website

1938 E Harney St Ste 253

Laramie, WY 82072

https://www.celldrop.co

CellDrop Biosciences in Laramie, WY is revolutionizing the field of living medicines through their patented ultrahigh viability encapsulation technology for allogeneic cell therapies. Their innovative platform addresses the limitations of current cell therapies by enabling the scalable production of off-the-shelf products while significantly enhancing therapeutic potential.

With a focus on equine stem cell therapy, CellDrop Biosciences offers an off-the-shelf allogeneic stem cell therapy to treat suspensory ligament and superficial digital flexor tendon injuries in performance horses. By keeping cells alive and localized at injury sites, their cutting-edge technology aims to improve therapeutic efficacy and redefine the future of cell therapy.

Generated from the website

Also at this address

IMPACT 307

Downrange Operations & Training LLC

Teton Simulation Software Inc

Manufacturing-Works

Own this business?

See a problem?

CO2Sync Inc

CO2Sync Inc, based in Laramie, WY, specializes in the development of genomically optimized plants for desired traits. Founded in 2019, the company is actively involved in the SBIR program, with a focus on genomics technology in plant breeding. With a recent award from the NSF for their project on genomically optimized turf grass, CO2Sync Inc is led by John D. Temte as President and Director. The company's innovative approach to plant genomics positions them as a key player in the field of sustainable agriculture and biotechnology. Generated from the website

Phytodetectors Inc

Phytodetectors Inc is a biotechnology company based in Wellington, CO that specializes in developing innovative plant-based detection systems. Utilizing cutting-edge technology, the company focuses on creating solutions for environmental monitoring and agricultural applications. Generated from their business information

PhotonPharma, Inc

PhotonPharma, Inc., located in Fort Collins, CO, is focused on developing innovative therapies for solid tumor cancers, specifically through their autologous therapy, Innocell. Currently, they are conducting a Phase 1 clinical study to evaluate the safety and immunogenicity of the Innocell autologous vaccine in patients with recurrent epithelial ovarian cancer. With ovarian cancer presenting significant challenges, including nearly 19,880 new cases and 12,810 deaths annually in the U.S., PhotonPharma aims to enhance treatment options by potentially delaying disease progression in conjunction with existing therapies. Their research is dedicated to improving outcomes for patients facing solid tumor malignancies. Generated from the website

United States›Wyoming›Laramie›CellDrop Biosciences